The U.S. House Appropriations Committee released its report accompanying the FY20 Defense Appropriations Act. It contains an increase to $30 million
The treatment part of this Phase 1 clinical trial for kidney cancer is over, now we're in the watching and waiting phase.
KidneyCan submitted a letter to the Congressional leadership of the House Appropriations Committee in early March. The letter was hand delivered